Analysis of the risk factors of linezolid‐related haematological toxicity in Chinese patients

A Reappraisal of Linezolid Dosing in Renal Impairment to Improve Safety

(2019) Ryan L. Crass et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Drug monitoring and individual dose optimization of antimicrobial drugs: oxazolidinones

(2016) Dario Cattaneo et al.   Expert Opinion on Drug Metabolism & Toxicology

Risk factors associated with high linezolid trough plasma concentrations

(2016) L. Morata et al.   EXPERT OPINION ON PHARMACOTHERAPY

A retrospective study of the risk factors for linezolid-induced thrombocytopenia and anemia

(2016) Yuki Hanai et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

High frequency of thrombocytopenia in patients with acute-on-chronic liver failure treated with linezolid

(2015) Yi-Min Zhang et al.   Hepatobiliary & Pancreatic Diseases International

Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis

(2015) Taeksun Song et al.   EBioMedicine

Clinical Population Pharmacokinetics and Toxicodynamics of Linezolid

(2014) Lauren M. Boak et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weight

(2014) Takashi Niwa et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Therapeutic drug monitoring and receiver operating characteristic curve prediction may reduce the development of linezolid-associated thrombocytopenia in critically ill patients

(2014) H.-Y. Dong et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Risk factors for linezolid-associated thrombocytopenia in adult patients

(2014) B. Natsumoto et al.   INFECTION

Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients

(2014) Kazuaki Matsumoto et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections

(2013) Dario Cattaneo et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopenia

(2013) Y. Nukui et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients

(2012) F. Pea et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Population Pharmacokinetic and Pharmacodynamic Analysis of Linezolid and a Hematologic Side Effect, Thrombocytopenia, in Japanese Patients

(2011) Tomohiro Sasaki et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Correlation between serum linezolid concentration and the development of thrombocytopenia

(2011) Yoichi Hiraki et al.   SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

Therapeutic Drug Monitoring of Linezolid: a Retrospective Monocentric Analysis

(2010) F. Pea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistantStaphylococcus aureus: vancomycin and linezolid

(2010) Gary E. Stein et al.   CURRENT MEDICAL RESEARCH AND OPINION

Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction

(2010) Kazuaki Matsumoto et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Chronic liver disease increases the risk of linezolid-related thrombocytopenia in methicillin-resistant Staphylococcus aureus-infected patients after digestive surgery

(2010) Shin-ichi Ikuta et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction

(2010) Yasuhiro Tsuji et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy

(2010) Yoshiko Takahashi et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

A comparison of linezolid with glycopeptides in severe MRSA pneumonia

(2009) Jafar Abunasser et al.   Expert Review of Anti-Infective Therapy

Linezolid: a review of safety and tolerability

(2009) Donald C. Vinh et al.   JOURNAL OF INFECTION

Pharmacologic options for CNS infections caused by resistant Gram-positive organisms

(2008) William J Peppard et al.   Expert Review of Anti-Infective Therapy